Description

Outline:

Introduction to allopathic drug management strategies in treating Alzheimer’s & Dementia in Canada.

Introduce current treatment goals, physiologic targets, and guiding principles for the clinical drug selection in dementia and Alzheimer’s disease treatment.

10 min

Comparing the 2 major drug classes involved in current established drug management options for Dementia & Alzheimer’s Disease and the four drugs used to treat Dementia & Alzheimer’s Disease in Canada:

(i) Cholinesterase Inhibitors:

• • Donepezil
  • Riastigmine
  • Galantamine

(ii) N-methy-D-aspartate receptor antagonist (NMDA): 35 min

• • Memantine

45 min

Drug discussion will include (with supportive clinical studies), discussion of mechanisms of action and clinical indications of use, contra-indications of use, side effects of drug use and herb/nutrient interactions.

45 min

Brief look at evolving treatment research and new strategies being investigated including up and coming biologics (disease-modifiers/immunotherapy):

• • Aducanumab
  • Gantenerumab
  • Donanemab
  • Lecanemab

15 min

Conclusion / Summary

5 min

Total: 2 hrs

As presented at our Live 2023 ND Conference: Naturopathic Approaches to Various Disorders